Keros Therapeutics KROS SEC Filings

NASDAQ KROS
$11.08 -0.23 (-2.04%)
As of: Sep 10, 2026 · 12:38 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Keros Therapeutics, Inc. (KROS) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index